Shortage Status

Status

Date Posted

Date Posted (dd-mm-yyyy)

  • GAPENTIN gabapentin 800 mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 26 Apr 2024

  • Pfizer (Australia) TOBRAMYCIN (as sulfate) 80 mg/2 mL

    Availability: Unavailable Deletion from market: 01 Oct 2024

  • TELZIR fosamprenavir 700mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Jul 2024

  • KARVEA irbesartan 75 mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 30 Aug 2024

  • AVAPRO irbesartan 75 mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 31 May 2024

  • VELCADE bortezomib 3.5 mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 30 Jun 2025
    View Detail

  • Pfizer (Australia) METHOTREXATE 50mg/2mL

    Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Dec 2024
    View Detail

  • DUROGESIC fentanyl 25 microgram

    Availability: Unavailable Deletion from market: 14 Apr 2025
    View Detail

  • DUROGESIC fentanyl 50 microgram

    Availability: Unavailable Deletion from market: 14 Apr 2025
    View Detail

  • DUROGESIC fentanyl 75 microgram

    Availability: Unavailable Deletion from market: 14 Apr 2025
    View Detail

  • DUROGESIC fentanyl 100 microgram

    Availability: Unavailable Deletion from market: 14 Apr 2025
    View Detail

  • Pfizer (Australia) CYTARABINE 1g/10mL

    Availability: Reduction in supply until supply is exhausted Deletion from market: 01 May 2024